Castlekeep Investment Advisors LLC Catalyst Pharmaceuticals, Inc. Transaction History

Castlekeep Investment Advisors LLC

  • $214 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025
BUY
$19.53 - $25.74 $1.64 Million - $2.16 Million
84,095 New
84,095 $2.04 Billion
Q4 2024

Feb 20, 2025
BUY
$19.73 - $23.93 $1.68 Million - $2.04 Million
85,059 New
85,059 $1.78 Billion
Q4 2024

Feb 14, 2025
BUY
$19.73 - $23.93 $35.4 Million - $43 Million
1,796,552 New
1,796,552 $143 Billion

Others Institutions Holding CPRX

# of Institutions
394
Shares Held
106M
Call Options Held
164K
Put Options Held
439K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.38B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Castlekeep Investment Advisors LLC Portfolio

Follow Castlekeep Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castlekeep Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castlekeep Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email